Male contraceptive gel in monkeys shows potential as an alternative to vasectomy

February 6, 2017, BioMed Central
Rhesus Monkeys are pictured at the California National Primate Research Centre. Credit: California National Primate Research Centre

A contraceptive gel has provided long-term and reliable contraception in male rhesus monkeys, according to research published in the open access journal Basic and Clinical Andrology. The product, called Vasalgel, which was trialled in rabbits in 2016, has the potential to be a reversible alternative to vasectomy.

Vasalgel is a non-pharmaceutical agent that forms a non-toxic hydrogel when injected into the vas deferens (the duct which conveys sperm from the testicle to the urethra). The gel fills the internal cavity of the vas deferens, forming a mechanical barrier to the movement of sperm. This method of contraception could one day be a viable alternative to a and, in this study, was able to prevent any conceptions occurring in a test group of 16 .

Dr Catherine VandeVoort, lead author from the California National Primate Research Centre, said: "Our research shows that Vasalgel placement into the vas deferens produces reliable contraception in mature male rhesus monkeys as shown by the lack of pregnancies in reproductively viable females with which the males were housed. Importantly, we show that the method of Vasalgel placement is safe and produced fewer complications than usually occur with a vasectomy."

Dr VandeVoort added: "Vasalgel shows real promise as an alternative to vasectomy because research in rabbits has previously shown the product to be reversible. Although it is possible to reverse a vasectomy, it is a technically challenging procedure and patients often have very low rates of fertility following reversal."

The researchers selected 16 adult male monkeys for surgery that involved injection of Vasalgel into the vas deferens. The monkeys were then monitored closely for 7 days for healthy recovery before being introduced back into their normal group housing. This consisted of large outdoor enclosures containing between 10-30 monkeys that included male and female infants, juveniles and adults. Each group had between one and three males that had been administered Vasalgel. The males were housed with their groups for at least one breeding season (approximately six months) and the authors report that no conceptions occurred. The expected pregnancy rate for sexually mature females in similar housing is approximately 80% per breeding season, according to the researchers.

One monkey out of the 16 that received Vasalgel showed signs of sperm granuloma (a hard build-up of sperm in the vas deferens) as a result of the injection. This is a common complication following a vasectomy, occurring in around 60% of cases in humans, according to the researchers. Discomfort or serious side effects caused by sperm granuloma are rare following a vasectomy. The researchers also state that the typical rate of sperm granuloma in male rhesus monkeys that have undergone vasectomy is around 15%.

The researchers say that future research should investigate the reversibility of Vasalgel placement in rhesus monkeys so that it can move forward as a potential alternative option to vasectomy for human males.

Explore further: Men welcome revolutionary male contraceptive

More information: Angela Colagross-Schouten et al, The contraceptive efficacy of intravas injection of Vasalgel™ for adult male rhesus monkeys, Basic and Clinical Andrology (2017). DOI: 10.1186/s12610-017-0048-9

Related Stories

Men welcome revolutionary male contraceptive

November 2, 2016
A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive the new contraceptive ...

Vasectomy reversal outcomes up with same partner as before

January 9, 2015
(HealthDay)—Fertility outcomes are improved for men who undergo vasectomy reversal and have the same female partner as before vasectomy, according to a study published in the January issue of The Journal of Urology.

Vasectomy not tied to decrease in sexual frequency

September 29, 2015
(HealthDay)—Vasectomy is not associated with decreased sexual frequency, according to a study published in the September issue of the Journal of Sexual Medicine.

Recommended for you

Living the high life: How altitude influences bone growth

June 19, 2018
High altitude is a particularly challenging environment—the terrain is physically challenging and the land has a relatively poor crop yield, so food can be sparse. Most importantly, oxygen levels are lower meaning that ...

Introduction of alcohol found to adversely impact fertility rates in hunter-gatherer community

June 19, 2018
Fernando Ramirez Rozzi, a research director with the French National Centre for Scientific Research has found that the introduction of alcohol to a Baka pygmy hunter-gatherer society caused fertility rates to fall. In his ...

Risks of cancer and mortality by average lifetime alcohol intake

June 19, 2018
The risk of mortality, and of developing a number of cancers, is lowest in light drinkers consuming an average of less than one drink per day across their lifetime, and the risk of some cancers increases with each additional ...

Bad habits that lead to cancer, chronic disease corrected by simple lifestyle intervention

June 19, 2018
Does this sound like someone you know? He or she spends too much time in front of screens, gets little exercise and eats a diet high in fat and low in fruits and vegetables.

Graphic warning labels linked to reduced sugary drink purchases

June 18, 2018
Warning labels that include photos linking sugary drink consumption with obesity, type 2 diabetes, and tooth decay, may reduce purchases of the drinks, according to a new study by researchers from Harvard T.H. Chan School ...

Greater levels of vitamin D associated with decreasing risk of breast cancer

June 15, 2018
Researchers at University of California San Diego School of Medicine suggest higher levels of vitamin D are associated with decreasing risk of breast cancer. Their epidemiological study is published in the June 15 online ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.